- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Paul R. Bessette
Insights 16 results
Article · Source: The D&O Diary
May 23, 2021
SPACs and SPAC-Related Litigation: A Primer on Reducing Litigation and Enforcement Risk
Client Alert
August 25, 2020
Court Dismisses Shareholder Suit Seeking To Recover Stock Drop from FDA Nonapproval of Experimental Drug
Article · Source: Bloomberg Law
May 12, 2020
Steps to Limit Exposure to Pharma, PPE Shareholder Lawsuits
Article · Source: Law360
May 4, 2020
Litigation Risks For Energy Executives During Bankruptcy
Client Alert
April 30, 2020
Litigation Risks For Energy Company Executives During Bankruptcy
Client Alert
Client Alert
March 12, 2020
Managing Securities Litigation Risks in a Time of Coronavirus Insecurities
Client Alert
September 23, 2015
Disclosure-Only Settlements Face Continued Scrutiny In Delaware
Client Alert
September 2, 2015
Delaware Chancery’s In re Dole Food Co., Inc. Decision Provides Lessons For Corporations Considering Going Private
Client Alert
May 19, 2015
Cornerstone Lets Directors Use 102(b)(7) Even Under Entire Fairness Review